These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10748157)

  • 1. Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase.
    Wu Y; Dowbenko D; Spencer S; Laura R; Lee J; Gu Q; Lasky LA
    J Biol Chem; 2000 Jul; 275(28):21477-85. PubMed ID: 10748157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2.
    Wu X; Hepner K; Castelino-Prabhu S; Do D; Kaye MB; Yuan XJ; Wood J; Ross C; Sawyers CL; Whang YE
    Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4233-8. PubMed ID: 10760291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases.
    Valiente M; Andrés-Pons A; Gomar B; Torres J; Gil A; Tapparel C; Antonarakis SE; Pulido R
    J Biol Chem; 2005 Aug; 280(32):28936-43. PubMed ID: 15951562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity.
    Koul D; Jasser SA; Lu Y; Davies MA; Shen R; Shi Y; Mills GB; Yung WK
    Oncogene; 2002 Apr; 21(15):2357-64. PubMed ID: 11948419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A selective irreversible inhibitor targeting a PDZ protein interaction domain.
    Fujii N; Haresco JJ; Novak KA; Stokoe D; Kuntz ID; Guy RK
    J Am Chem Soc; 2003 Oct; 125(40):12074-5. PubMed ID: 14518976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC.
    Haas-Kogan D; Shalev N; Wong M; Mills G; Yount G; Stokoe D
    Curr Biol; 1998 Oct; 8(21):1195-8. PubMed ID: 9799739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN 2, a Golgi-associated testis-specific homologue of the PTEN tumor suppressor lipid phosphatase.
    Wu Y; Dowbenko D; Pisabarro MT; Dillard-Telm L; Koeppen H; Lasky LA
    J Biol Chem; 2001 Jun; 276(24):21745-53. PubMed ID: 11279206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex.
    Vazquez F; Grossman SR; Takahashi Y; Rokas MV; Nakamura N; Sellers WR
    J Biol Chem; 2001 Dec; 276(52):48627-30. PubMed ID: 11707428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth, downregulates phosphorylated Akt, and increases sensitivity to doxorubicin.
    Tanaka M; Grossman HB
    Gene Ther; 2003 Sep; 10(19):1636-42. PubMed ID: 12923562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis.
    Davies MA; Lu Y; Sano T; Fang X; Tang P; LaPushin R; Koul D; Bookstein R; Stokoe D; Yung WK; Mills GB; Steck PA
    Cancer Res; 1998 Dec; 58(23):5285-90. PubMed ID: 9850049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions.
    Leslie NR; Bennett D; Gray A; Pass I; Hoang-Xuan K; Downes CP
    Biochem J; 2001 Jul; 357(Pt 2):427-35. PubMed ID: 11439092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN.
    Davies MA; Koul D; Dhesi H; Berman R; McDonnell TJ; McConkey D; Yung WK; Steck PA
    Cancer Res; 1999 Jun; 59(11):2551-6. PubMed ID: 10363971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppressor MMAC/PTEN inhibits cytokine-induced NFkappaB activation without interfering with the IkappaB degradation pathway.
    Koul D; Yao Y; Abbruzzese JL; Yung WK; Reddy SA
    J Biol Chem; 2001 Apr; 276(14):11402-8. PubMed ID: 11278366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAGI-1: a widely expressed, alternatively spliced tight junction protein.
    Laura RP; Ross S; Koeppen H; Lasky LA
    Exp Cell Res; 2002 May; 275(2):155-70. PubMed ID: 11969287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma membrane Ca2+-atpase isoforms 2b and 4b interact promiscuously and selectively with members of the membrane-associated guanylate kinase family of PDZ (PSD95/Dlg/ZO-1) domain-containing proteins.
    DeMarco SJ; Strehler EE
    J Biol Chem; 2001 Jun; 276(24):21594-600. PubMed ID: 11274188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells.
    Davies MA; Kim SJ; Parikh NU; Dong Z; Bucana CD; Gallick GE
    Clin Cancer Res; 2002 Jun; 8(6):1904-14. PubMed ID: 12060635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN.
    Koul D; Parthasarathy R; Shen R; Davies MA; Jasser SA; Chintala SK; Rao JS; Sun Y; Benvenisite EN; Liu TJ; Yung WK
    Oncogene; 2001 Oct; 20(46):6669-78. PubMed ID: 11709701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of the MAGI-1b/PTEN signalosome in stabilization of adherens junctions and suppression of invasiveness.
    Kotelevets L; van Hengel J; Bruyneel E; Mareel M; van Roy F; Chastre E
    FASEB J; 2005 Jan; 19(1):115-7. PubMed ID: 15629897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region.
    Georgescu MM; Kirsch KH; Akagi T; Shishido T; Hanafusa H
    Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10182-7. PubMed ID: 10468583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association.
    Lee JO; Yang H; Georgescu MM; Di Cristofano A; Maehama T; Shi Y; Dixon JE; Pandolfi P; Pavletich NP
    Cell; 1999 Oct; 99(3):323-34. PubMed ID: 10555148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.